These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 11396980)
21. FHIT gene alterations in esophageal cancer and ulcerative colitis (UC). Zou TT; Lei J; Shi YQ; Yin J; Wang S; Souza RF; Kong D; Shimada Y; Smolinski KN; Greenwald BD; Abraham JM; Harpaz N; Meltzer SJ Oncogene; 1997 Jul; 15(1):101-5. PubMed ID: 9233782 [TBL] [Abstract][Full Text] [Related]
22. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours. Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528 [TBL] [Abstract][Full Text] [Related]
24. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
25. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Sozzi G; Pastorino U; Moiraghi L; Tagliabue E; Pezzella F; Ghirelli C; Tornielli S; Sard L; Huebner K; Pierotti MA; Croce CM; Pilotti S Cancer Res; 1998 Nov; 58(22):5032-7. PubMed ID: 9823304 [TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of the FHIT gene in human prostate cancer. Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683 [TBL] [Abstract][Full Text] [Related]
27. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533 [TBL] [Abstract][Full Text] [Related]
28. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection. Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215 [TBL] [Abstract][Full Text] [Related]
29. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness. Yoon SO Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614 [TBL] [Abstract][Full Text] [Related]
30. Alterations of the FHIT gene in human hepatocellular carcinoma. Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123 [TBL] [Abstract][Full Text] [Related]
31. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue. Tokuchi Y; Kobayashi Y; Hayashi S; Hayashi M; Tanimoto K; Hashimoto T; Nishida K; Ishikawa Y; Nakagawa K; Satoh Y; Yamamoto M; Tsuchiya E Genes Chromosomes Cancer; 1999 Feb; 24(2):105-11. PubMed ID: 9885976 [TBL] [Abstract][Full Text] [Related]
32. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines. Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505 [TBL] [Abstract][Full Text] [Related]
33. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas. Gray SE; Kay E; Leader M; Mabruk M J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825 [TBL] [Abstract][Full Text] [Related]
34. FHIT mutations in human primary gastric cancer. Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441 [TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters. Skopelitou AS; Mitselou A; Katsanos KH; Alexopoulou V; Tsianos EV Eur J Gastroenterol Hepatol; 2003 May; 15(5):515-23. PubMed ID: 12702909 [TBL] [Abstract][Full Text] [Related]
36. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992 [TBL] [Abstract][Full Text] [Related]
37. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816 [TBL] [Abstract][Full Text] [Related]
38. Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis. Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703 [TBL] [Abstract][Full Text] [Related]
39. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival. Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602 [TBL] [Abstract][Full Text] [Related]
40. Aberrant FHIT transcripts in human colorectal cancers. Lee SH; Lee SH Res Commun Mol Pathol Pharmacol; 2005; 117-118():153-65. PubMed ID: 18426086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]